|Bid||112.61 x 1000|
|Ask||119.88 x 900|
|Day's range||116.09 - 118.65|
|52-week range||105.31 - 165.03|
|Beta (5Y monthly)||1.16|
|PE ratio (TTM)||112.08|
|Forward dividend & yield||0.96 (0.82%)|
|Ex-dividend date||28 Mar 2022|
|1y target est||N/A|
Investors are optimistic about Zimmer Biomet's (ZBH) better-than-expected revenues and robust performance across several geographies.
Each of Zimmer Biomet's (ZBH) geographic segments and product divisions recorded year-over-year sales growth at CER.
Zimmer (ZBH) delivered earnings and revenue surprises of 15% and 4.10%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?